Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Endothelial potassium channels as therapeutic targets to enhance nitric oxide signalling
FY 2013-14
Summary
Nitric oxide (NO) produced by the vascular endothelium elicits relaxation of surrounding smooth muscle cells to cause vasodilation and protects blood vessels from the deleterious consequences of platelet aggregation and activation of inflammatory responses. In disease states, endothelial dysfunction leads to decreased NO synthesis and increased scavenging of NO by reactive oxygen species (ROS) which disrupts the above processes. This contributes to clinical manifestations such as high blood pressure, accelerated atherosclerosis and thrombosis which are in turn associated with significant morbidity and mortality. Currently, there are no effective treatments to overcome the multiple consequences of decreased availability of NO. It is well-established that the release of NO in response to agonists and physical factors, such as shear stress, occurs concurrently with the opening of calcium-activated potassium (KCa) channels causing the hyperpolarization of the endothelial cell membrane potential. Recent data from our lab has shown that commercially available small molecule activators of endothelial KCa channels may reduce ROS production and enhance NO-mediated vasorelaxation in large conduit arteries isolated from animals with endothelial dysfunction. We have shown that these effects occur without vasodilation which means that endothelial function may be enhanced whilst coupling between physiological stimuli and changes in blood flow are maintained and thus, triggering of baroreceptor reflexes would be avoided.
The specific aim of my project is to explore the relationship between activation of endothelial KCa channels, NO availability and ROS production in resistance arteries in health and disease. To address this aim I will use a combination of functional and biochemical techniques to define the relationship between opening of endothelial KCa channels and NO availability. NO-mediated relaxation of arterial smooth muscle will be assessed using wire myography, production of NO and ROS will be measured using immunofluorescent and biochemical assays, and activation of endothelial KCa channels will be recorded using sharp glass microelectrodes. These approaches will be applied to arteries and cells from both diabetic and non-diabetic animals so that I can establish the mechanism of action of KCa channel modulators under control conditions and in the setting of endothelial dysfunction. The data generated will provide new mechanistic information on endothelial cell membrane potential as a determinant of NO bioavailability and whether small molecule KCa openers may provide an endothelium-targeted anti-oxidant strategy to overcome endothelial dysfunction. All of the required techniques are established and the project builds on the techniques and experiences I gained during my undergraduate research. The project will allow me to develop the necessary skills required for me to progress towards my goal of becoming an independent biomedical researcher.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311787
Name
Lunn Stephanie E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Endothelial potassium channels as therapeutic targets to enhance nitric oxide signalling
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atherosclerosis; Cardiovascular Disease; Diabetes; Endothelial Calcium Activated Potassium Channels; Endothelium; Hypertension; Nitric Oxide Signalling; Thrombosis
Abstract
Nitric oxide (NO) produced by the vascular endothelium elicits relaxation of surrounding smooth muscle cells to cause vasodilation and protects blood vessels from the deleterious consequences of platelet aggregation and activation of inflammatory responses. In disease states, endothelial dysfunction leads to decreased NO synthesis and increased scavenging of NO by reactive oxygen species (ROS) which disrupts the above processes. This contributes to clinical manifestations such as high blood pressure, accelerated atherosclerosis and thrombosis which are in turn associated with significant morbidity and mortality. Currently, there are no effective treatments to overcome the multiple consequences of decreased availability of NO. It is well-established that the release of NO in response to agonists and physical factors, such as shear stress, occurs concurrently with the opening of calcium-activated potassium (KCa) channels causing the hyperpolarization of the endothelial cell membrane potential. Recent data from our lab has shown that commercially available small molecule activators of endothelial KCa channels may reduce ROS production and enhance NO-mediated vasorelaxation in large conduit arteries isolated from animals with endothelial dysfunction. We have shown that these effects occur without vasodilation which means that endothelial function may be enhanced whilst coupling between physiological stimuli and changes in blood flow are maintained and thus, triggering of baroreceptor reflexes would be avoided.
The specific aim of my project is to explore the relationship between activation of endothelial KCa channels, NO availability and ROS production in resistance arteries in health and disease. To address this aim I will use a combination of functional and biochemical techniques to define the relationship between opening of endothelial KCa channels and NO availability. NO-mediated relaxation of arterial smooth muscle will be assessed using wire myography, production of NO and ROS will be measured using immunofluorescent and biochemical assays, and activation of endothelial KCa channels will be recorded using sharp glass microelectrodes. These approaches will be applied to arteries and cells from both diabetic and non-diabetic animals so that I can establish the mechanism of action of KCa channel modulators under control conditions and in the setting of endothelial dysfunction. The data generated will provide new mechanistic information on endothelial cell membrane potential as a determinant of NO bioavailability and whether small molecule KCa openers may provide an endothelium-targeted anti-oxidant strategy to overcome endothelial dysfunction. All of the required techniques are established and the project builds on the techniques and experiences I gained during my undergraduate research. The project will allow me to develop the necessary skills required for me to progress towards my goal of becoming an independent biomedical researcher.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lunn, Stephanie E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~